Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agios Pharmaceuticals (NQ: AGIO )

47.75 USD +1.79 (+3.89%)
Official Closing Price Updated: 5:00 PM EST, Jan 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Agios Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
– Supplemental New Drug Application Planned for Submission in Q1 2021 – 
From GlobeNewswire News Releases
Interesting AGIO Put And Call Options For March 19th
Investors in Agios Pharmaceuticals Inc (AGIO) saw new options begin trading this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AGIO... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Small Cap AGIO PFE
From Benzinga
Noteworthy ETF Outflows: XBI, NTLA, AGIO, SAGE
Symbols mentioned in this story: XBI, NTLA, AGIO, SAGE Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation
From GlobeNewswire News Releases
Notable ETF Outflow Detected - XBI, AGIO, SAGE, IONS
Symbols mentioned in this story: XBI, AGIO, SAGE, IONS Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Agios to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021
From GlobeNewswire News Releases
Analysts Anticipate 20% Gains Ahead For The Holdings of FBT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Should Investors Consider These Top Biotech Stocks To Buy? 3 Names To Watch
Tags Market News
From Stockmarket.com
4 Reasons Agios' Oncology Deal Should Please Investors
Agios' newly revamped business strategy is an extreme departure from the company's original mission, but it's a great deal for shareholders. 
Tags RPRX Market News BMY
From Motley Fool
82 Biggest Movers From Yesterday
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares surged 60.4% to close at $24.60 on Monday. Nantkwest Inc ... 
Tags QS QTNT LIXT
From Benzinga
Noteworthy Monday Option Activity: OPY, DDOG, AGIO
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Oppenheimer Holdings Inc Class A (D (OPY), where a total volume of 885 contracts... 
Tags Stocks
From Market News Video
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers NantKwest (NASDAQ:NK) stock rose 57.4% to $16.15 during Monday's regular session. As of 12:31 EST, this ... 
Tags Market News QURE HJLI
From Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the ... 
Tags PFE AGIO BHC
From Benzinga
55 Stocks Moving In Monday's Mid-Day Session
Gainers 500.com Limited (NYSE: WBAI) shares climbed 125.7% to $6.07 after the company announced a $23 million investment from ... 
Tags LIXT FGF CURO
From Benzinga
Why Agios Pharmaceuticals Stock Is Soaring Today
Investors applauded the company's planned sale of its oncology portfolio. 
Tags AGIO Market News
From Motley Fool
Biopharma M&A Continues: Agios Sells Oncology Portfolio, NantKwest's Reverse Merger With ImmunityBio, Eyegate Picks Up Panoptes
M&A momentum in the biopharma space picked up pace, with a few more deals announced in the space this week. Agios To Divest ... 
Tags AGIO Small Cap NK
From Benzinga
Thinking about buying stock in Agios Pharmaceuticals, Clovis Oncology, Aqua Metals, Cocrystal Pharma, or Luminar Technologies?
InvestorsObserver issues critical PriceWatch Alerts for AGIO, CLVS, AQMS, COCP, and LAZR. 
From PR Newswire
Agios Pharmaceuticals Stock Rockets On $2 Billion Oncology Business Sale
Agios Pharmaceuticals will sell its oncology business to Servier for up to $2 billion, the biotech company said Monday. In response, AGIO stock skyrocketed by double digits. 
From Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG) shares increased by 84.31% to $6.58 during Monday's pre-market ... 
Tags FGEN Benzinga Pre/Market Outlook
From Benzinga
Agios to Focus on Developing and Commercializing Innovative Treatments for Genetically Defined Diseases and Sell Its Oncology Business to Servier for Up to $2 Billion Plus Royalties
From GlobeNewswire News Releases
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NVTA NGM INBX
From Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the ... 
Tags INO Options AMRN
From Benzinga
71 Biggest Movers From Yesterday
Gainers Curis, Inc. (NASDAQ: CRIS) stock climbed 354.9% to close at $6.55 on Tuesday after the company announced ... 
Tags INFI Pre/Market Outlook News
From Benzinga
12 Healthcare Stocks Moving In Tuesday's Intraday Session
Gainers Curis (NASDAQ:CRIS) stock increased by 337.15% to $6.29 during Tuesday's regular session. Trading volume for ... 
Tags Markets PEN CMD
From Benzinga
52 Stocks Moving In Tuesday's Mid-Day Session
Gainers Curis, Inc. (NASDAQ: CRIS) stock jumped 323% to $6.09 after the company announced "positive" preliminary data ... 
Tags COUP News CGIX
From Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FOLD MRVI AXSM
From Benzinga
Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease
From GlobeNewswire News Releases
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ... 
Tags FDA American Society of Hematology IMRA
From Benzinga
Agios Announces the Phase 3 ACTIVATE Trial of Mitapivat Achieved Its Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.